-
Symbol
-
BCAX on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.0001 per share
-
Latest Disclosed Shares Owned
-
5,216,969 shares
-
Security Ownership %
-
9.6%
Raymond Debbane ownership in Bicara Therapeutics Inc. Common Stock, par value $0.0001 per share (BCAX)
31 Jul 2025 - Raymond Debbane has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,216,969 shares of Bicara Therapeutics Inc. Common Stock, par value $0.0001 per share (BCAX).
This represents 9.6% ownership of the company.
This is the first filing by Invus Global Management, LLC disclosing ownership of Bicara Therapeutics Inc. Common Stock, par value $0.0001 per share (BCAX).